AVKARE LLC recalls Glycopyrrolate Tablets, USP, 1 mg, 50 Tablets (5x10) Unit Dose carton, Rx Only, Manufactured for: AvKARE Pulaski, TN 38…
- Recall date
- December 22, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0091-2023
- FDA classification
- Class II
- Brand / firm
- AVKARE LLC
- Sold / distributed
- USA Nationwide
Why it was recalled
Failed impurities/degradation specifications: Out of specification for unknown impurities.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Glycopyrrolate Tablets, USP, 1 mg, 50 Tablets (5x10) Unit Dose carton, Rx Only, Manufactured for: AvKARE Pulaski, TN 38478, NDC 50268-363-15
Get recall alerts
Free email alert whenever AVKARE LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: AVKARE LLC